0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
A. Gordon Smith, MD
Arch Intern Med. 2012;172(2):132-133. doi:10.1001/archinternmed.2011.1718.

Original Investigation |  FREE
A. Gordon Smith, MD; J. Robinson Singleton, MD
Arch Intern Med. 2004;164(9):1021-1025. doi:10.1001/archinte.164.9.1021.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Editorial  | 
Targeting the Interleukin 6 Receptor to Treat Neuromyelitis Optica
Sarosh R. Irani, MD, DPhil; Angela Vincent, FRCPath
JAMA Neurology
Original Investigation  | 
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein, MD; Ilya Ayzenberg, MD; Jens Harmel, MD; et al.
JAMA Neurology
Original Investigation  | 
Risk of Neuropathy Among 28 232 Patients With Biopsy-Verified Celiac Disease
Sujata P. Thawani, MD, MPH; Thomas H. Brannagan III, MD; Benjamin Lebwohl, MD, MS; et al.
JAMA Neurology
Original Investigation  | 
Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia
Carlo Rinaldi, MD, PhD; Thomas Schmidt, PhD; Alan J. Situ, BS; et al.